OBJECTIVE: To compare cytomegalovirus (CMV) strains found in cerebrospinal fluid (CSF) of patients with HIV infection and CMV encephalitis with those present in the general population with respect to genetic variation in the N terminus of the glycoprotein B (gBn)-gene. DESIGN AND METHODS: We sequenced gBn, which is a major target of the antiviral immune response, of CMV strains present in CSF of nine HIV-infected patients with acute encephalitis, in serum of 18 immunocompetent patients with primary CMV infection, and in serum of nine HIV-infected patients without neurological illness. Sequences were compared to prototype strains and analysed by use of phylogeny. RESULTS: Fourty-four percent (4/9) of gBn-sequences present in CSF did not cluster with any of the four gBn-prototype strains. Phylogenetic analysis revealed that these sequences represented two further, distinct genotypes and comparison of sequences was highly suggestive for intragenic recombination. In immunocompetent patients and HIV-infected patients without neurological illness, genotype gBn1 was the predominant strain (4/9, 44% and 8/18, 42%, respectively). Genotypes distinct from prototype strains were found in none of the immunocompetent patients and 22% (2/9) of HIV- infected patients without neurological illness. CONCLUSIONS: CMV strains present in CSF of HIV-infected patients with encephalitis differ significantly from those present in the general population. Intragenic recombination of CMV may be common in patients with advanced HIV infection and a source of new CMV strains with altered biological properties.
OBJECTIVE: To compare cytomegalovirus (CMV) strains found in cerebrospinal fluid (CSF) of patients with HIV infection and CMV encephalitis with those present in the general population with respect to genetic variation in the N terminus of the glycoprotein B (gBn)-gene. DESIGN AND METHODS: We sequenced gBn, which is a major target of the antiviral immune response, of CMV strains present in CSF of nine HIV-infectedpatients with acute encephalitis, in serum of 18 immunocompetent patients with primary CMV infection, and in serum of nine HIV-infectedpatients without neurological illness. Sequences were compared to prototype strains and analysed by use of phylogeny. RESULTS: Fourty-four percent (4/9) of gBn-sequences present in CSF did not cluster with any of the four gBn-prototype strains. Phylogenetic analysis revealed that these sequences represented two further, distinct genotypes and comparison of sequences was highly suggestive for intragenic recombination. In immunocompetent patients and HIV-infectedpatients without neurological illness, genotype gBn1 was the predominant strain (4/9, 44% and 8/18, 42%, respectively). Genotypes distinct from prototype strains were found in none of the immunocompetent patients and 22% (2/9) of HIV- infectedpatients without neurological illness. CONCLUSIONS: CMV strains present in CSF of HIV-infectedpatients with encephalitis differ significantly from those present in the general population. Intragenic recombination of CMV may be common in patients with advanced HIV infection and a source of new CMV strains with altered biological properties.
Authors: Patrick C Y Woo; Susanna K P Lau; Cyril C Y Yip; Yi Huang; Hoi-Wah Tsoi; Kwok-Hung Chan; Kwok-Yung Yuen Journal: J Virol Date: 2006-07 Impact factor: 5.103
Authors: M Rycel; W Wujcicka; B Zawilińska; E Paradowska; P Suski; Z Gaj; J Wilczyński; Z Leśnikowski; D Nowakowska Journal: Eur J Clin Microbiol Infect Dis Date: 2014-10-28 Impact factor: 3.267
Authors: Brenda Evelin Barreto da Silva; Victor Santana Santos; Ingrid Emmily Reis Santos; Marcus Vinicius de Aragão Batista; Leila Luiza Conceição Gonçalves; Lígia Mara Dolce de Lemos Journal: Rev Soc Bras Med Trop Date: 2019-12-20 Impact factor: 1.581
Authors: Katrina Vanura; Franz Rieder; Marie-Theres Kastner; Julia Biebl; Michael Sandhofer; Trang Le; Robert Strassl; Elisabeth Puchhammer-Stöckl; Thomas Perkmann; Christoph F Steininger; Kostas Stamatopoulos; Wolfgang Graninger; Ulrich Jäger; Christoph Steininger Journal: PLoS One Date: 2013-10-23 Impact factor: 3.240
Authors: Florent Lassalle; Daniel P Depledge; Matthew B Reeves; Amanda C Brown; Mette T Christiansen; Helena J Tutill; Rachel J Williams; Katja Einer-Jensen; Jolyon Holdstock; Claire Atkinson; Julianne R Brown; Freek B van Loenen; Duncan A Clark; Paul D Griffiths; Georges M G M Verjans; Martin Schutten; Richard S B Milne; Francois Balloux; Judith Breuer Journal: Virus Evol Date: 2016-06-15